Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL
Clinical trial NCT03460522 · UNKNOWN
Trial details
- NCT number
- NCT03460522
- Sponsor
- Nicola Goekbuget
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2025-06-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.